Developing small-molecule drugs for hard-to-drug targets remains one of the toughest challenges in modern drug discovery. Targets like cytokines, transcription factors, and scaffolding proteins often lack well-defined…
Isotopic Labeling in Mammalian Expression: The Missing Link for NMR Studies of Hard-to-Express Proteins
ZoBio is excited to introduce a new exclusive capability for making complex protein samples for drug discovery: isotopic labeling during mammalian expression. This ability provides the missing link between…
Using SEC-MALS to Validate BRICHOS Oligomer Structures
The BRICHOS domain is a molecular chaperone known for its ability to prevent amyloid and amorphous protein aggregation, playing a critical role in protecting cells from protein misfolding. ZoBio has an active collaboration with the Karolinska Institutet, where we are exploring the Bri2 BRICHOS…
We Are ZoBio
Step into the world of ZoBio and discover what makes us unique. Featuring our incredible team, this video captures the heart of our company – our values, our innovation, and the people who bring it all to life. From everyday interactions to groundbreaking projects, we showcase why ZoBio is a place where passion meets purpose.